Immune Surveillance and Tumor Evasion

  • M. Katherine Jung


Tumors are composed of heterogeneous cell types, both diverse transformed cells of the tissue of origin and a variety of stromal cells. The tumor cells themselves differ in the degree of aneuploidy, the number and identity of mutations, the extent of genomic instability, the expression of surface antigens, and the capacity to express cytokines, growth factors, proteases, and angiogenic factors. The stromal cells include fibroblasts, an assortment of leukocytes and lymphocytes, and often cell types that make up blood vessels. Ongoing reciprocal interactions between tumor cells and stromal cells affect the establishment, progression, and maintenance of cancer, with immune cells in particular mediating antitumor surveillance (Fig. 10.1). This chapter explores the details of immune surveillance, discusses the mechanisms by which tumors evade this surveillance, and explores the impact of alcohol on both.


Vascular Endothelial Growth Factor Natural Killer Cell Immune Surveillance Chronic Alcohol Natural Killer Cell Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


B cell

Bone marrow-derived lymphocyte






Myeloid-derived suppressor cells


Major histocompatibility complex


Nuclear factor kappa-light-chain-enhancer of ­activated B cells


Natural killer (cells)


Natural killer T (cells)


Signal transducer and activator of transcription

T cell

Thymus-derived lymphocyte


Transporter associated with antigen processing


Transforming growth factor beta

Th1 and Th2

CD4+ T helper cells


Tumor necrosis factor alpha


Regulatory T cells


Vascular endothelial growth factor


  1. Adkis CA, Blaser K (2001) Mechanisms of interleukin-10-mediated immune suppression. Immunology 103:131–6.CrossRefGoogle Scholar
  2. Algarra I, Collado A, Garrido F (1997) Altered MHC class I antigens in tumors. Int J Clin Lab Res 27:95–102.PubMedCrossRefGoogle Scholar
  3. Ben-Eliyahu S, Page GG, Yirmiya R, Taylor AN (1996) Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat Med.2:457–60.Google Scholar
  4. Bierie B, Moses HL (2010) Transforming growth factor beta (TGF-β) and inflammation in cancer. Cytokine Growth Factor Rev 21:49–59.PubMedCrossRefGoogle Scholar
  5. Blank SE, Meadows GG (1996) Ethanol modulates metastatic potential of B16BL6 melanoma and host responses. Alcohol Clin Exp Res 20:624–8.PubMedCrossRefGoogle Scholar
  6. Cabrera T, Angustias Fernandez M, Sierra A, Garrido A, Herruzo A, Escobedo A, Fabra A, Garrido F (1996) High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum Immunol 50:127–34.PubMedCrossRefGoogle Scholar
  7. Cook RT (1998) Alcohol abuse, alcoholism, and damage to the immune system – a review. Alcohol Clin Exp Res 22:1927–42.PubMedGoogle Scholar
  8. Cook RT, Garvey MJ, Booth BM, Goeken JA, Stewart B, Noel M (1991) Activated CD-8 cells and HLA DR expression in alcoholics without overt liver disease. J Clin Immunol 11:246–53.PubMedCrossRefGoogle Scholar
  9. Cook RT, Li F, Vandersteen D, Ballas ZK, Cook BL, LaBrecque DR (1997) Ethanol and natural killer cells. I. Activity and immunophenotype in alcoholic humans. Alcohol Clin Exp Res 21:974–80.Google Scholar
  10. Cook RT, Waldschmidt TJ, Ballas ZK, Cook BL, Booth BM, Stewart BC, Garvey MJ ( 1994) Fine T-cell subsets in alcoholics as determined by the expression of l-selectin, leukocyte common antigen, and beta-integrin. Alcohol Clin Exp Res 18:71–80.PubMedCrossRefGoogle Scholar
  11. Cook RT, Zhu X, Coleman RA, Ballas ZK, Waldschmidt TJ, Ray NB, LaBrecque DR, Cook BL (2004) T-cell activation after chronic ethanol ingestion in mice. Alcohol 33:175–81.PubMedCrossRefGoogle Scholar
  12. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA (2004) NK cell and DC interactions. Trends Immunol 25:47–52.PubMedCrossRefGoogle Scholar
  13. Cretney EJ, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ (2002) Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol 168:1356–61.PubMedGoogle Scholar
  14. Curiel TJ (2007) Tregs and rethinking cancer immunotherapy. J Clin Invest. 117:1167–74.PubMedCrossRefGoogle Scholar
  15. DeNardo DG, Andreu P, Coussens LM (2010) Interactions between lymphocytes and myeloid cells regulate pro-versus anti-tumor immunity. Cancer Metastasis Rev 29:309–16.Google Scholar
  16. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunol 3:991–8.CrossRefGoogle Scholar
  17. Fuchs EJ, Matzinger P (1996) Is cancer dangerous to the immune system? Semin Immunol 8:271–80.PubMedCrossRefGoogle Scholar
  18. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc P, Trajanoski Z, Fridman W, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–4.PubMedCrossRefGoogle Scholar
  19. Garrido F, Ruiz-Cabello F, Cabrera T, Pérez-Villar JJ, López-Botet M, Duggan-Keen M, Stern PL (1997) Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 18:89–95.PubMedCrossRefGoogle Scholar
  20. Gerosa F, Gobbi A, Zorzi P, Burg S, Briere F, Carra G, Trinchieri G (2005) The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174:727–34.PubMedGoogle Scholar
  21. Godfrey DI, Stankovic S, Baxter AG (2010) Raising the NKT cell family. Nature Immunol 11:197–206.CrossRefGoogle Scholar
  22. Gurung P, Young BM, Coleman RA, Wiechert S, Turner LE, Ray NB, Waldschmidt TJ, Legge KL, Cook RT ( 2009) Chronic ethanol induces inhibition of antigen-specific CD8+ but not CD4+ immunodominant T cell responses following Listeria monocytogenes inoculation. J Leukoc Biol 85:34–43.PubMedCrossRefGoogle Scholar
  23. Hanson EM, Clements VK, Sinha P, Ilkovitch D, Ostrand-Rosenberg S ( 2009) Myeloid-derived suppressor cells down-regulate l-selectin expression on CD4+ and CD8+ T cells. J Immunol 183:937–44.PubMedCrossRefGoogle Scholar
  24. Hayashi T, Faustman DL (2002) Development of spontaneous uterine tumors in low molecular mass polypeptide-2 knockout mice. Cancer Res 62:24–7.PubMedGoogle Scholar
  25. Hofbauer GF, Kamarashev J, Geertsen R, Böni R, Dummer R. (1998) Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. Melanoma Res 8:337–43.PubMedCrossRefGoogle Scholar
  26. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H (1998) The central role of CD4+ T cells in the antitumor immune response. J Exp Med 188:2357–68.PubMedCrossRefGoogle Scholar
  27. Irwin M, Miller C (2000) Decreased natural killer cell responses and altered interleukin-6 and interleukin-10 production in alcoholism: an interaction between alcohol dependence and African-American ethnicity. Alcohol Clin Exp Res 24:560–9.PubMedCrossRefGoogle Scholar
  28. Khong HT, Restifo NP (2002) Natural selection of tumor variants in the generation of “tumor escape” phenotypes. Nature Immunol 3:999–1005.CrossRefGoogle Scholar
  29. Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC (1996) Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br J Cancer 73:148–53.PubMedCrossRefGoogle Scholar
  30. Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, Niu G, Kay H, Mule J, Kerr WG, Jove R, Pardoll D, Yu H (2005) Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nature Med 11:1314–21.PubMedCrossRefGoogle Scholar
  31. Laso FJ, Iglesias-Osma C, Ciudad J, López A, Pastor I, Orfao A (1999) Chronic alcoholism is associated with an imbalanced production of Th-1/Th-2 cytokines by peripheral blood T cells. Alcohol Clin Exp Res 23:1306–11.PubMedCrossRefGoogle Scholar
  32. Laso FJ, Almeida J, Torres E, Vaquero JM, Marcos M, Orfao A (2010) Chronic Alcohol Consumption Is Associated With an Increased Cytotoxic Profile of Circulating Lymphocytes That May Be Related With the Development of Liver Injury. Alcohol Clin Exp Res 34 [Epub ahead of print].Google Scholar
  33. Lau AH, Abe M, Thomson AW (2006) Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo. J Leukoc Biol 79:941–53.PubMedCrossRefGoogle Scholar
  34. Leek RD, Harris AL (2002) Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 7:177–89.Google Scholar
  35. Mandrekar P, Catalano D, Dolganiuc A, Kodys K, Szabo G (2004) Inhibition of myeloid dendritic cell accessory cell function and induction of T cell anergy by alcohol correlates with decreased IL-12 production. J Immunol 173:3398–3407.PubMedGoogle Scholar
  36. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301–5.PubMedCrossRefGoogle Scholar
  37. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–44.PubMedCrossRefGoogle Scholar
  38. Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, Bonecchi R (2010) The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 21:27–39.PubMedCrossRefGoogle Scholar
  39. Minagawa M, Deng Q, Liu ZX, Tsukamoto H, Dennert G (2004) Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 126:1387–99.PubMedCrossRefGoogle Scholar
  40. Motivala SJ, Dang, J, Obradovic T, Meadows GG, Butch AW, Irwin MR (2003) Leptin and cellular and innate immunity in abstinent alcoholics and controls. Alcohol Clin Exp Res 27:1819–24.PubMedCrossRefGoogle Scholar
  41. Noonan DM, De Lerma Barbaro A, Vannini N, Mortara L, Albini A (2008) Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev 27:31–40.PubMedCrossRefGoogle Scholar
  42. Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mulé JJ, Rosenberg SA, Bennink JR (1993) Identification of human cancers deficient in antigen processing. J Exp Med 177:265–72.PubMedCrossRefGoogle Scholar
  43. Sawanobori Y, Ueha S, Kurachi M, Shimaoka T, Talmadge JE, Abe J, Shono Y, Kitabatake M, Kakimi K, Mukaida N, Matsushima K (2008) Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111:5457–66.PubMedCrossRefGoogle Scholar
  44. Seliger B, Höhne A, Jung D, Kallfelz M, Knuth A, Jaeger E, Bernhard H, Momburg F, Tampé R, Huber C (1997) Expression and function of the peptide transporters in escape variants of human renal cell carcinomas. Exp Hematol 25:608–14.PubMedGoogle Scholar
  45. Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G, Zanovello P, Bronte V (2004) Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother 53:64–72.PubMedCrossRefGoogle Scholar
  46. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD (2001) IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107–11.PubMedCrossRefGoogle Scholar
  47. Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA (2010) Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328:749–752.PubMedCrossRefGoogle Scholar
  48. Shojaei F, Wu X, Zhong C, Yu L, Liang XH, Yao J, Blanchard D, Bais C, Peale FV, van Bruggen N, Ho C, Ross J, Tan M, Carano RA, Meng YG, Ferrara N (2007) Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450:825–31.PubMedCrossRefGoogle Scholar
  49. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S (2007) Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 179:977–83.PubMedGoogle Scholar
  50. Smyth MJ, Thia KYT, Street SEA, MacGregor D, Godfrey DI, Trapani JA (2000a) Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 192:755–60.PubMedCrossRefGoogle Scholar
  51. Smyth MJ, Thia KYT, Street SEA, Cretney E, Trapani, JA, Taniguchi M, Kawano T, Pelikan SB, Crowe NY, Godfrey DI (2000b) Differential Tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 191:661–68.PubMedCrossRefGoogle Scholar
  52. Song K, Coleman RA, Alber C, Ballas ZK, Waldschmidt TJ, Mortari F, LaBrecque DR, Cook RT (2001) TH1 cytokine response of CD57+ T-cell subsets in healthy controls and patients with alcoholic liver disease. Alcohol 24:155–67.PubMedCrossRefGoogle Scholar
  53. Song K, Coleman RA, Zhu X, Alber C, Ballas ZK, Waldschmidt TJ, Cook RT (2002) Chronic ethanol consumption by mice results in activated splenic T cells. J Leukoc Biol 72:1109–16.PubMedGoogle Scholar
  54. Spies CD, von Dossow V, Eggers V, Jetschmann G, El-Hilali R, Egert J, Fischer M, Schröder T, Höflich C, Sinha P, Paschen C, Mirsalim P, Brunsch R, Hopf J, Marks C, Wernecke KD, Pragst F, Ehrenreich H, Müller C, Tonnesen H, Oelkers W, Rohde W, Stein C, Kox WJ. (2004) Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients. Anesthesiology. 100:1088–100PubMedCrossRefGoogle Scholar
  55. Spitzer JH, Meadows GG (1999) Modulation of perforin, granzyme A, and granzyme B in murine natural killer (NK), IL2 stimulated NK, and lymphokine-activated killer cells by alcohol consumption. Cell Immunol 194:205–12.PubMedCrossRefGoogle Scholar
  56. Spitzer JH, Núñez NP, Meadows SA, Gallucci RM, Blank SE, Meadows GG (2000) The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice. Alcohol Clin Exp Res 24:837–44.PubMedCrossRefGoogle Scholar
  57. Starkenburg S, Munroe ME, Waltenbaugh (2001) Early alteration in leukocyte populations and Th1/Th2 function in ethanol-consuming mice. Alcohol Clin Exp Res 25:1221–30.Google Scholar
  58. Stout RD, Watkins SK, Suttles J. (2009) Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J Leukoc Biol. 86:1105–9.PubMedCrossRefGoogle Scholar
  59. Street SEA, Trapani JA, MacGregor D, Smyth MJ (2002) Suppression of lymphoma and epithelial malignancies effected by interferon γ. J Exp Med 196:129–34.PubMedCrossRefGoogle Scholar
  60. Surman DR, Dudley ME, Overwijk WW, Restifo NP (2000) Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen. J Immunol 164:562–5.PubMedGoogle Scholar
  61. Swann JB, Uldrich AP, van Dommelen S, Sharkey J, Murray WK, Godfrey DI, Smyth MJ (2009) Type I natural killer T cells suppress tumors caused by p53 loss in mice. Blood 113:6382–5.PubMedCrossRefGoogle Scholar
  62. Szabo G (1999) Consequences of alcohol consumption on host defence. Alcohol Alcohol 34:830–41.PubMedGoogle Scholar
  63. Szabo G, Catalano D, White B, Mandrekar P (2004) Acute alcohol consumption inhibits accessory cell function of monocytes and dendritic cells. Alcohol Clin Exp Res 28:824–8.PubMedCrossRefGoogle Scholar
  64. Szabo G, Mandrekar P (2009) A recent perspective on alcohol, immunity and host defense. Alcohol Clin Exp Res 33:1–13.CrossRefGoogle Scholar
  65. Tan W, Bailey AP, Shparago M, Busby B, Covington J, Johnson JW, Young E, Gu JW (2007) Chronic alcohol consumption stimulates VEGF expression, tumor angiogenesis and progression of melanoma in mice. Cancer Biol Ther 6:1211–17.PubMedCrossRefGoogle Scholar
  66. Trinchieri G, Pflanz S, Kastelein RA (2003) The IL-12 Family of heterodimeric cytokines: New players in the regulation of T cell responses. Immunity 19:641–4.PubMedCrossRefGoogle Scholar
  67. Wang T, Niu G, Kortylewski M, Burdeyla L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, Dalton W, Jove R, Pardoll D, Yu H (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nature Med 10:48–54.PubMedCrossRefGoogle Scholar
  68. Wu WJ, Pruett SB (1999) Ethanol decreases host resistance to pulmonary metastases in a mouse model: role of natural killer cells and the ethanol-induced stress response. Int J Cancer 82:886–92.PubMedCrossRefGoogle Scholar
  69. Xiang R, Lode HN, Gillies SD, Reisfeld RA (1999) T cell memory against colon carcinoma is long-lived in the absence of antigen. J Immunol 163:3676–83.PubMedGoogle Scholar
  70. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC, Moses HL (2008) Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13:23–35.PubMedCrossRefGoogle Scholar
  71. Yang R, Roden RBS (2007) Re: The Terminology Issue for Myeloid-Derived Suppressor Cells. Cancer Res 67:426.CrossRefGoogle Scholar
  72. Yu H, Kortylewski M, Pardoll D (2007) Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nature Rev Immunol 7:41–51.CrossRefGoogle Scholar
  73. Zhang H, Meadows GG (2005) Chronic alcohol consumption in mice increases the proportion of peripheral memory T cells by homeostatic proliferation. J Leukoc Biol 78:1070–80.PubMedGoogle Scholar
  74. Zhang H, Meadows GG (2008) Chronic alcohol consumption perturbs the balance between thymus-derived and bone marrow-derived natural killer cells in the spleen. J Leukocyte Biol 83:41–47.PubMedCrossRefGoogle Scholar
  75. Zhang H, Meadows GG (2010) Chronic alcohol consumption enhances myeloid-derived suppressor cells in B16BL6 melanoma-bearing mice. Cancer Immunol Immunother Mar 13 [Epub ahead of print].Google Scholar
  76. Zhou J, Meadows GG (2003) Alcohol consumption decreases IL-2-induced NF-kappaB activity in enriched NK cells from C57BL/6 mice. Toxicol Sci 73:72–9.PubMedCrossRefGoogle Scholar
  77. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier LL (2005) NK cell regulation of T cell-mediated responses. Mol Immunol 42:451–4.PubMedCrossRefGoogle Scholar
  78. Zitvogel L, Terme M, Borg C, Trinchieri G (2006) Dendritic cell-NK cell cross-talk: regulation and physiopathology. Curr Top Microbiol Immunol 298:157–74.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Division of Metabolism and Health EffectsNational Institute on Alcohol Abuse and Alcoholism, National Institutes of HealthBethesdaUSA

Personalised recommendations